Literature DB >> 26460850

Monitoring Neutrophil-Expressed Cell Surface Esophageal Cancer Related Gene-4 after Severe Burn Injury.

Todd W Costantini1, Raul Coimbra1, Nicole E Lopez1, Jeanne G Lee1, Bruce Potenza1, Alan Smith1, Andrew Baird1, Brian P Eliceiri1.   

Abstract

BACKGROUND: We identified recently esophageal cancer related gene-4 (ECRG4) as a candidate cytokine that is expressed on the surface of quiescent polymorphonuclear leukocytes (PMNs) and shed in response to ex vivo treatment with lipopolysaccharide. To investigate the potential biologic relevance of changes in cell surface ECRG4 in human samples, we performed a pilot study to examine a population of burn patients in whom blood could be analyzed prospectively. We hypothesized that cutaneous burn injury would alter cell surface expression of ECRG4 on PMNs.
METHODS: Patients admitted with more than 20% total burn surface area (TBSA) (n = 10) had blood collected at the time of admission and weekly thereafter. For comparison, blood was obtained from a control group of healthy human volunteers (n = 4). We used flow cytometry to measure changes in ECRG4(+) PMNs from patients during recovery from injury. Esophageal cancer related gene-4 expression at each time point was compared with the patient's clinical status based on a Multiple Organ Dysfunction (MOD) score.
RESULTS: Esophageal cancer related gene-4 was detected on the PMN surface of cells collected from healthy volunteers, however, within 48 h of admission after burn injury (n = 10 patients), the number of PMNs with cell surface ECRG4 was decreased. Esophageal cancer related gene-4 expression in PMNs was re-established over the course of patient recovery, unless complications occurred. In this case, the decrease in cell surface ECRG4(+) PMNs preceded the clinical diagnosis of infectious complications and was reflected by increased organ injury scores.
CONCLUSION: From a small sample set, we were able to determine that PMN cell surface ECRG4 expression was decreased after burn injury and returned to baseline during recovery from injury. Although larger studies are needed to define the role of ECRG4 in human PMNs further, this report is the first assessment of cell surface ECRG4 protein in a patient population to support analogous findings in animal studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26460850      PMCID: PMC4663648          DOI: 10.1089/sur.2014.209

Source DB:  PubMed          Journal:  Surg Infect (Larchmt)        ISSN: 1096-2964            Impact factor:   2.150


  26 in total

1.  The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.

Authors:  Hilary F Clark; Austin L Gurney; Evangeline Abaya; Kevin Baker; Daryl Baldwin; Jennifer Brush; Jian Chen; Bernard Chow; Clarissa Chui; Craig Crowley; Bridget Currell; Bethanne Deuel; Patrick Dowd; Dan Eaton; Jessica Foster; Christopher Grimaldi; Qimin Gu; Philip E Hass; Sherry Heldens; Arthur Huang; Hok Seon Kim; Laura Klimowski; Yisheng Jin; Stephanie Johnson; James Lee; Lhney Lewis; Dongzhou Liao; Melanie Mark; Edward Robbie; Celina Sanchez; Jill Schoenfeld; Somasekar Seshagiri; Laura Simmons; Jennifer Singh; Victoria Smith; Jeremy Stinson; Alicia Vagts; Richard Vandlen; Colin Watanabe; David Wieand; Kathryn Woods; Ming-Hong Xie; Daniel Yansura; Sothy Yi; Guoying Yu; Jean Yuan; Min Zhang; Zemin Zhang; Audrey Goddard; William I Wood; Paul Godowski; Alane Gray
Journal:  Genome Res       Date:  2003-09-15       Impact factor: 9.043

2.  Analysis of factorial time-course microarrays with application to a clinical study of burn injury.

Authors:  Baiyu Zhou; Weihong Xu; David Herndon; Ronald Tompkins; Ronald Davis; Wenzhong Xiao; Wing Hung Wong; Mehmet Toner; H Shaw Warren; David A Schoenfeld; Laurence Rahme; Grace P McDonald-Smith; Douglas Hayden; Philip Mason; Shawn Fagan; Yong-Ming Yu; J Perren Cobb; Daniel G Remick; John A Mannick; James A Lederer; Richard L Gamelli; Geoffrey M Silver; Michael A West; Michael B Shapiro; Richard Smith; David G Camp; Weijun Qian; John Storey; Michael Mindrinos; Rob Tibshirani; Stephen Lowry; Steven Calvano; Irshad Chaudry; Michael A West; Mitchell Cohen; Ernest E Moore; Jeffrey Johnson; Lyle L Moldawer; Henry V Baker; Philip A Efron; Ulysses G J Balis; Timothy R Billiar; Juan B Ochoa; Jason L Sperry; Carol L Miller-Graziano; Asit K De; Paul E Bankey; Celeste C Finnerty; Marc G Jeschke; Joseph P Minei; Brett D Arnoldo; John L Hunt; Jureta Horton; J Perren Cobb; Bernard Brownstein; Bradley Freeman; Ronald V Maier; Avery B Nathens; Joseph Cuschieri; Nicole Gibran; Matthew Klein; Grant O'Keefe
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

3.  Promoter methylation of esophageal cancer-related gene 4 in gastric cancer tissue and its clinical significance.

Authors:  Yu-Bin Wang; Cai-Feng Ba
Journal:  Hepatogastroenterology       Date:  2012-09

4.  Esophageal cancer-related gene 4 is a secreted inducer of cell senescence expressed by aged CNS precursor cells.

Authors:  Yuki Kujuro; Norihiro Suzuki; Toru Kondo
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-19       Impact factor: 11.205

5.  Cell-specific processing and release of the hormone-like precursor and candidate tumor suppressor gene product, Ecrg4.

Authors:  Xitong Dang; Sonia Podvin; Raul Coimbra; Brian Eliceiri; Andrew Baird
Journal:  Cell Tissue Res       Date:  2012-04-18       Impact factor: 5.249

6.  The changing pattern and implications of multiple organ failure after blunt injury with hemorrhagic shock.

Authors:  Joseph P Minei; Joseph Cuschieri; Jason Sperry; Ernest E Moore; Michael A West; Brian G Harbrecht; Grant E O'Keefe; Mitchell J Cohen; Lyle L Moldawer; Ronald G Tompkins; Ronald V Maier
Journal:  Crit Care Med       Date:  2012-04       Impact factor: 7.598

7.  Pulmonary preconditioning, injury, and inflammation modulate expression of the candidate tumor suppressor gene ECRG4 in lung.

Authors:  Steven Kao; Ashkaun Shaterian; David M Cauvi; Xitong Dang; Hyun Bae Chun; Antonio De Maio; Todd W Costantini; Raul Coimbra; Brian P Eliceiri; Andrew Baird
Journal:  Exp Lung Res       Date:  2014-12-16       Impact factor: 2.459

8.  Esophageal cancer-related gene-4 (ECRG4) interactions with the innate immunity receptor complex.

Authors:  Sonia Podvin; Xitong Dang; Morgan Meads; Arwa Kurabi; Todd Costantini; Brian P Eliceiri; Andrew Baird; Raul Coimbra
Journal:  Inflamm Res       Date:  2014-12-16       Impact factor: 4.575

9.  Genome-wide census and expression profiling of chicken neuropeptide and prohormone convertase genes.

Authors:  K R Delfino; B R Southey; J V Sweedler; S L Rodriguez-Zas
Journal:  Neuropeptides       Date:  2009-12-14       Impact factor: 3.286

10.  Expression of ECRG4 is an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.

Authors:  Yoichiro Mori; Hideyuki Ishiguro; Yoshiyuki Kuwabara; Masahiro Kimura; Akira Mitsui; Horoki Kurehara; Ryota Mori; Keisuke Tomoda; Ryo Ogawa; Takeyasu Katada; Koshiro Harata; Yoshitaka Fujii
Journal:  Oncol Rep       Date:  2007-10       Impact factor: 3.906

View more
  3 in total

Review 1.  Potential functions of esophageal cancer-related gene-4 in the cardiovascular system.

Authors:  Rui Zhou; Yuanshu Liu; Wenjun Huang; Xitong Dang
Journal:  Front Med       Date:  2019-08-29       Impact factor: 4.592

Review 2.  ECRG4: a new potential target in precision medicine.

Authors:  Xin Qin; Ping Zhang
Journal:  Front Med       Date:  2018-07-12       Impact factor: 4.592

3.  ECRG4 regulates neutrophil recruitment and CD44 expression during the inflammatory response to injury.

Authors:  Robert A Dorschner; Jisook Lee; Olga Cohen; Todd Costantini; Andrew Baird; Brian P Eliceiri
Journal:  Sci Adv       Date:  2020-03-11       Impact factor: 14.957

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.